Skip header and navigation

105 records – page 1 of 11.

Document Type
Evidence Search Report
Review Code
EOC033101-01 ESR
Question Submitted
March 31, 2020
Date Completed
March 31, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033101-01 ESR
Question Submitted
March 31, 2020
Date Completed
March 31, 2020
Status
3. Completed
Research Team
EOC
Notes
No written rapid review
Category
Infection Prevention and Control
Subject
Aerosols
Surgical Procedures
Risk
Population
All
Clinical Setting
Medicine Unit
Priority Level
Level 2 completed within 8 hours
Cite As
Dalidowicz, M. What is the magnitude of risk of exposure to coronaviruses with intermediate and high risk upper GI endoscopy, ERCP and colonoscopy? 2020 Mar 31; Document no.: EOC033101-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 9 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033001-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033001-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Subject
Intubation
Aerosols
Population
All
Clinical Setting
Ambulatory
Cardiac unit
Priority Level
Level 2 completed within 8 hours
Cite As
Dalidowicz, M. Where and how are they producing and using intubation hoods? 2020 Mar 30; Document no.: EOC033001-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 6 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EPM040901-01 ESR
Question Submitted
April 9, 2020
Date Completed
April 9, 2020
Status
3. Completed
Research Team
Epidemiology & Modelling
Document Type
Evidence Search Report
Review Code
EPM040901-01 ESR
Question Submitted
April 9, 2020
Date Completed
April 9, 2020
Status
3. Completed
Research Team
Epidemiology & Modelling
Notes
Written Rapid Review was not produced.
Category
Infection Prevention and Control
Subject
Saskatchewan
Indigenous
Public Health
Population
Indigenous Peoples
Priority Level
Level 2 completed within 8 hours
Cite As
Young, C; Mueller, M. What are the best practices for COVID-19 response and control in indigenous populations in Northern Saskatchewan and in on-reserve communities? 2020 Apr 24; Document no.: EPM040901-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 24 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033004-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033004-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Subject
Households
Transmission
Priority Level
Level 5 completed within 2 weeks
Cite As
Fox, L. What are effective methods to reduce disease transmission within households? 2020 Mar 30; Document no.: EOC033004-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 7 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
VPL041601-01 ESR
Question Submitted
April 18, 2020
Date Completed
May 26, 2020
Status
3. Completed
Research Team
Vulnerable Populations
Document Type
Evidence Search Report
Review Code
VPL041601-01 ESR
Question Submitted
April 18, 2020
Date Completed
May 26, 2020
Status
3. Completed
Research Team
Vulnerable Populations
Category
Infection Prevention and Control
Subject
Vulnerable Populations
Self-Isolation
Priority Level
Level 2 completed within 8 hours
Cite As
Young, C; Dalidowicz, M; Howell-Spooner, B. What are the best practices for self-isolation for transient populations? 2020 May 26; Document no.: VPL041601-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 20 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
VPL041602-01 ESR
Question Submitted
April 19, 2020
Date Completed
April 19, 2020
Status
3. Completed
Research Team
Vulnerable Populations
Document Type
Evidence Search Report
Review Code
VPL041602-01 ESR
Question Submitted
April 19, 2020
Date Completed
April 19, 2020
Status
3. Completed
Research Team
Vulnerable Populations
Category
Infection Prevention and Control
Subject
Vulnerable Populations
Self-Isolation
Harm Reduction
Priority Level
Level 3 completed within 2-3 days
Cite As
Young, C; Dalidowicz, M; Howell-Spooner, B. What are the best practices for delivery of harm reduction services to people who are self-isolating? 2020 May 27; Document no.: VPL041602-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 15 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
VPL041601 RR
Question Submitted
April 18, 2020
Date Completed
April 19, 2020
Status
3. Completed
Research Team
Vulnerable Populations
Document Type
Rapid Review
Review Code
VPL041601 RR
Question Submitted
April 18, 2020
Date Completed
April 19, 2020
Status
3. Completed
Research Team
Vulnerable Populations
Key Findings
Across also sources reviewed, the ideal scenario is provision of safe self-isolating spacesin private accommodation(ideally own room and bathroom) through negotiations with hotels/hostels/community centers
Where self-isolation in private accommodation is not possible, consider risk stratification and cohorting of residentsin congregate sheltersalong a continuum of(cases/suspected)to (asymptomatic/medically vulnerable); recognizing the resulting impact of reduced bed density on bed capacity
Ideally designate shelters by cohort with testing and transfer protocols in place·Ensure infection control measures are in place, both at the institutional and personal infection control level –including education and visual cues.
Designate staff to specific cohortswith no transfer of staff between sites/cohorts·For those remainingon the streets/ sheltering outside, distribute supplies (water, hand sanitizer, food), information (symptomsphysical distancing, and access to health care), and provide access to public washrooms/ portable toilets & handwashing facilities
Working with established tent cities or establishing tent cities may be important to consider
Category
Infection Prevention and Control
Subject
Vulnerable Populations
Self-Isolation
Priority Level
Level 2 completed within 8 hours
Cite As
Badea, A; Abonyi, S; Hanson, L; Bourassa, C; Dalidowicz, M; Young, C; Howell-Spooner, B. What are the best practices for self-isolation for transient populations? 2020 Apr 19; Document no.: VPL041601 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 11 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
VPL041602 RR
Question Submitted
April 19, 2020
Date Completed
April 19, 2020
Status
3. Completed
Research Team
Vulnerable Populations
Document Type
Rapid Review
Review Code
VPL041602 RR
Question Submitted
April 19, 2020
Date Completed
April 19, 2020
Status
3. Completed
Research Team
Vulnerable Populations
Key Findings
Reassessing procedures ofopioid agonist therapy(OAT)–reducing requirements to allow more to access OAT
Considerations of reducing contact by increasing duration of OAT carries for those previously ineligible, and ensuring closing of provision gaps due to weekends/stat holidays/etc.
Increased provision ofsuppliesfor patients
Changes to controlled substance regulations allow for phamacists to extend prescriptions, transfer prescriptions to other pharmacists, accept refills/prescriptions from providers by phone, and allowing the delivery of controlled substances; Recommendations around the prescription of “safe supply” of stimulants and illicit benzodiazepines include the prescription of low-dose medications under (virtual) supervision to reduce the potential for withdrawal
Deferring medical withdrawal management and dose reductions, considerations of transitioning to lower risk OAT
Ensuring access to culturally relevant psychosocial support, and allowing for pharmacological treatment without a requirement of abstinence or psychosocial therapy
Category
Infection Prevention and Control
Subject
Vulnerable Populations
Self-Isolation
Harm Reduction
Priority Level
Level 3 completed within 2-3 days
Cite As
Badea, A; Fornssler, B; Dalidowicz, M; Young, C; Howell-Spooner, B. What are the best practices for delivery of harm reduction services to people who are self-isolating 2020 Apr 20; Document no.: VPL041602 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 10 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC033001 RR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC033001 RR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· Some countries like Taiwan and Malaysia have created their own intubation hood design as others offered to produce or modify the original design to fit their country’s equipment. · Several countries have also created innovation in airway management such as 3D printed respirator valves for hospitals and 3D printed ventilators. · An Emergency physician in Northern Italy shared that due to influx of patients in the hospitals, “intubation and invasive mechanical ventilators in the ED are reserved for patients not responsive to NIV” although in principle can give a more favorable chance for patients if given before their condition deteriorates.
Category
Infection Prevention and Control
Subject
Intubation
Aerosols
Population
All
Clinical Setting
Ambulatory
Cardiac unit
Priority Level
Level 2 completed within 8 hours
Cite As
Badea, A; Groot, G; Dalidowicz, M. Where and how are they producing and using intubation hoods? 2020 Mar 30; Document no.: EOC033001 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 7 p. (CEST rapid review report)
Similar Reviews
EOC090202 RR
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
PH061201-01 ESR
Question Submitted
June 12, 2020
Date Completed
June 12, 2020
Status
3. Completed
Research Team
Public Health
Document Type
Evidence Search Report
Review Code
PH061201-01 ESR
Question Submitted
June 12, 2020
Date Completed
June 12, 2020
Status
3. Completed
Research Team
Public Health
Category
Infection Prevention and Control
Subject
Communal Living
Transmission
Population
All Pediatrics
All adults
Aged (80+)
Clinical Setting
Community
Public Health
Priority Level
Level 3 completed within 2-3 days
Cite As
Howell-Spooner, B; Miller, L. How are Hutterite colonies responding to and coping with COVID-19 prevention and outbreaks? 2020 Jun 12; Document no.: PH061201-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 10 p. (CEST evidence search report)
Related Documents
Documents
Less detail

105 records – page 1 of 11.